HL: Second-Line Sintilimab Plus Chemo Bests Chemo Alone ...Middle East

Medscape - News
HL: Second-Line Sintilimab Plus Chemo Bests Chemo Alone
Use of the PD-1 inhibitor sintilimab in combination with ICE chemotherapy as a second-line treatment in classical Hodgkin lymphoma shows impressive response rates vs chemo alone in the phase 3 ORIENT-21 trial. Medscape Medical News

Hence then, the article about hl second line sintilimab plus chemo bests chemo alone was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( HL: Second-Line Sintilimab Plus Chemo Bests Chemo Alone )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News